Form 990 for tax year 2022
Filed by INTERNATIONAL CANCER ADVOCACY NETWORK.
Totals
- Total revenue
- $1,357,826
- Total expenses
- $915,666
- Contributions and grants received
- $1,378,104
- Grants paid
- $290,100
- Program service revenue
- $0
- Investment income
- -$1,317
- Other revenue
- -$18,961
- Total assets, end of year
- $3,351,569
- Total liabilities, end of year
- $7,393
- Net assets or fund balances, end of year
- $3,344,176
- Program services expenses (Part IX)
- $849,838
- Management and general expenses
- $55,818
- Fundraising expenses
- $10,010
- Program service expenses (Part III)
- $849,838
Program services were 92.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$134,168
-
1f · All other contributions, gifts and grants
$1,243,936
-
1g · Noncash contributions included above
$356,129
-
3 · Investment income
total $3,327 · excluded $3,327
-
7a · Gross sales of assets other than inventory
securities $357,356
-
7b · Less cost or other basis and sales expenses
securities $362,000
-
7c · Gain or loss
securities -$4,644
-
7d · Net gain or loss
total -$4,644 · excluded -$4,644
-
8a · Fundraising events: gross income
$21,980
-
8a · Fundraising events: contributions included on line 1c
$134,168
-
8b · Fundraising events: direct expenses
$40,941
-
8c · Net income from fundraising events
total -$18,961 · excluded -$18,961
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $290,100 · program services $290,100
-
5 · Compensation of officers, directors and key employees
total $172,000 · program services $163,400 · management and general $3,440 · fundraising $5,160
-
9 · Other employee benefits
total $20,666 · program services $19,633 · management and general $413 · fundraising $620
-
10 · Payroll taxes
total $11,608 · program services $11,028 · management and general $232 · fundraising $348
-
11b · Fees: legal
total $516 · management and general $516
-
11c · Fees: accounting
total $8,450 · management and general $8,450
-
11g · Fees: other
total $278,465 · program services $247,465 · management and general $31,000
-
12 · Advertising and promotion
total $1,163 · program services $1,163
-
13 · Office expenses
total $37,472 · program services $32,655 · management and general $935 · fundraising $3,882
-
14 · Information technology
total $3,298 · program services $3,298
-
16 · Occupancy
total $33,101 · program services $26,189 · management and general $6,912
-
19 · Conferences, conventions and meetings
total $48,617 · program services $48,617
-
22 · Depreciation, depletion and amortization
total $857 · program services $857
-
23 · Insurance
total $4,502 · program services $1,351 · management and general $3,151
-
24a · Other expenses: DUES AND SEMINARS
total $2,482 · program services $2,217 · management and general $265
-
24b · Other expenses: BOOKS AND SUBSCRIPTIONS
total $2,012 · program services $1,683 · management and general $329
-
24c · Other expenses: BOARD/COMM DEVELOPMENT
total $172 · program services $172
-
24d · Other expenses: BANK CHARGES
total $155 · management and general $155
-
24e · All other expenses
total $30 · program services $10 · management and general $20
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $1,143,994 · end of year $1,229,914
-
2 · Savings and temporary cash investments
beginning of year $1,086,087 · end of year $1,446,769
-
10a · Land, buildings and equipment: cost or other basis
$661,505
-
10b · Land, buildings and equipment: accumulated depreciation
$7,711
-
10c · Land, buildings and equipment, net
beginning of year $646,665 · end of year $653,794
-
11 · Investments: publicly traded securities
beginning of year $20,160 · end of year $14,290
-
15 · Other assets
end of year $6,802
-
17 · Accounts payable and accrued expenses
beginning of year $2,875 · end of year $7,393
-
27 · Net assets without donor restrictions
beginning of year $2,894,031 · end of year $3,344,176
Mission and programs · 2022
Mission
ICAN'S MISSION IS TO ASSIST STAGE IV CANCER PATIENTS WITH DIRECT PATIENT NAVIGATION AND CUSTOMIZED ADVOCACY SERVICES, INCLUDING PHYSICIAN REFERRALS, AND ACCESS TO MOLECULAR PROFILING, CLINICAL TRIALS, AND COMPASSIONATE USE/EXPANDED ACCESS PROGRAMS. ICAN IS A PAN-HEME, PAN-TUMOR, AND PAN-RARE CANCER PATIENT ADVOCACY ORGANIZATION AND RESEARCH ADVOCACY ORGANIZATION. ICAN ALSO FOCUSES ON EXPANDING PATIENT ACCESS AND REDUCING HEALTH DISPARITIES. FROM TIME TO TIME, WE WILL AWARD GRANTS BASED ON SPECIAL EVENT REVENUES OR RESEARCH CAMPAIGNS TO SUPPORT OUR WORK TO DEFEAT RARE CANCERS, BUT ICAN'S PRIMARY MISSION IS OUR PATIENT PROGRAM SERVICES AND RESEARCH SERVICES ASSISTING CANCER PATIENTS AND THEIR CARE PARTNERS TO ENHANCE SURVIVAL AND ATTAIN THE HIGHEST POSSIBLE QUALITY OF LIFE. SEE ASKICAN.ORG AND EXON20GROUP.ORG
Activities or mission (Part I)
ICAN ASSISTS STAGE IV CANCER PATIENTS WITH DIRECT PATIENT NAVIGATION AND CUSTOMIZED ADVOCACY SERVICES, INCLUDING PHYSICIAN REFERRALS, AS WELL AS ACCESS TO MOLECULAR PROFILING AND CLINICAL TRIALS.
-
Withheld by Nonprofiteer: this text may name a private individual.
Expenses $422,719 · Grants $290,100
-
PATIENT, CARE PARTNER, AND CLINICIAN EDUCATION/ U.S. AND GLOBAL PATIENT ACCESS PROGRAMS-FOCUSING ON PATIENT ACCESS TO MOLECULAR TESTING AND PRECISION MEDICINE; U.S. AND GLOBAL HEALTH EQUITY ISSUES; EARLY DETECTION (IMAGING AND MOLECULAR DIAGNOSTICS); ONGOING HEALTH INFORMATION PROJECTS; AND ACCESS ISSUES REGARDING EXPANDED ACCESS/PRE-APPROVAL ACCESS/COMPASSIONATE USE PROGRAMS IN THE U.S. AND COUNTRIES OUTSIDE THE U.S.
Expenses $193,340 · Revenue $233,779
-
MOLECULAR PROFILING CONNECTION SERVICES/CLINICAL TRIALS MATCHING SERVICES--ADVISING PATIENTS ON THE IMPORTANCE OF NEXT-GENERATION SEQUENCING AND MOLECULAR PROFILING (GENOMICS, PROTEOMICS, TRANSCRIPTOMICS, AND IMMUNE CELL STUDIES); REVIEWING MOLECULAR PROFILING REPORTS WITH PATIENTS AND THEIR CARE PARTNERS, CONVENING AD HOC MOLECULAR TUMOR BOARDS WHERE NEEDED; CONNECTING PATIENTS TO PRINCIPAL INVESTIGATORS AND STUDY TEAMS ON PAN- TUMOR/PAN-HEME/PAN-RARE CANCER BASIS. THE ORGANIZATION SPECIALIZES IN CLINICAL TRIAL ACCRUAL AND RETENTION ISSUES AS WELL AS CLINICAL TRIALS SITE SELECTION ISSUES. ONGOING WORK ON DECENTRALIZING TRIALS AND JUST-IN-TIME TRIAL CONCEPTS AS WELL AS TRANSFERRING PATIENTS FROM ONE CLINICAL TRIALS SITE TO ANOTHER MORE CONVENIENT SITE.
Expenses $233,779
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.
Listed in Part VII
-
SHERRY WEINSTEIN
CHAIR-TTEES-
- Total calculated
- $0
- Hours/week
- 30
-
ROBERT H TAMIS MD DECD NOV 22
VICE CHAIR S
- Total calculated
- $0
- Hours/week
- 20
-
MARCIA K HORN JD
PRESIDENT AN
- Total calculated
- $192,666
- From this org
- $172,000
- From related orgs
- $0
- Other
- $20,666
- Hours/week
- 90
Schedule J breakdown matched by us
- Base
- $172,000
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $20,666
- Filer's total
- $192,666
-
CATHY DALZELL
CHAIR ADIVIS
- Total calculated
- $0
- Hours/week
- 5
-
CHERYL J HINTZEN-GAINES
CHAIR-HONORA
- Total calculated
- $0
- Hours/week
- 3
-
SIDNEY M ROSEN ESQ
FOUNDING CHA
- Total calculated
- $0
- Hours/week
- 10
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Form 990 of other organizations
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
HEYMACH LAB-MD ANDERSON CANCER CNTR
$150,100
LUNG CANCER RESEARCH
-
IMMUNOTHERAPY RESRCH
-
LUNG CANCER RESEARCH FOUNDATION
$37,500
UCSF GRANT
-
CANCER RESEARCH
-
$20,000
EARLY DETECTION
-
$10,000
SARCOMA RESEARCH
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 13 November 2023
- IRS schema version
- 2022v5.0
- Source object
- 202343179349311174
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.